Table 1 Baseline patient and tumor characteristics
Characteristic | Total (n = 15) |
|---|---|
Age, (years) | |
Mean (SD) | 71.5 (8.8) |
Median [range] | 73.0 [55.0–84.0] |
IQR | 65.0–78.0 |
Sex, n (%) | |
Female | 1 (7%) |
Male | 14 (93%) |
ECOG at treatment, n (%) | |
0 | 7 (47%) |
1 | 8 (53%) |
Duration of cemiplimab treatment (months) | |
Median (range) | 22 (8–24) |